Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidermal Nevus Syndrome (ENS)”

3 trials

Showing 3 of 3 results

Post-approval studies (Phase 4)Study completedNCT04320316
What this trial is testing

A Trial to Assess the Safety and Efficacy of KRN23 in Epidermal Nevus Syndrome (ENS)

Who this might be right for
Epidermal Nevus Syndrome
University of Alabama at Birmingham 1
Large-scale testing (Phase 3)Study completedNCT03581591
What this trial is testing

Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic Rickets

Who this might be right for
HypophosphatemiaHypophosphatemic RicketsPain, Chronic
Redwood Dermatology Sciences 1
Testing effectiveness (Phase 2)Study completedNCT02304367
What this trial is testing

Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)

Who this might be right for
Tumor Induced Osteomalacia (TIO)Epidermal Nevus Syndrome (ENS)
Kyowa Kirin, Inc. 17

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation